<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6193783C-53EE-49CE-BD1B-0C41A6F978ED"><gtr:id>6193783C-53EE-49CE-BD1B-0C41A6F978ED</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Hill</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FEC4050B-15C0-4989-88C8-10DD2BBE7290"><gtr:id>FEC4050B-15C0-4989-88C8-10DD2BBE7290</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>Briddon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09335656-19CE-4A23-89BD-973ADA9AEF88"><gtr:id>09335656-19CE-4A23-89BD-973ADA9AEF88</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Searle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800006"><gtr:id>FB3FF50F-D9CD-4525-B532-DBC8473CCCFF</gtr:id><gtr:title>Use of fluorescence correlation spectroscopy to study the adenosine A3-receptor in microdomains of single living cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800006</gtr:grantReference><gtr:abstractText>Adenosine is a molecule that is released from cells in response to a range of stimulants and binds to specialised docking sites on the outside of neighbouring cells to pass on chemical signals in the form of changes in the level of intracellular messengers. The specialised docking sites on the surface of cells that recognise adenosine are called adenosine receptors. These are members of the G protein-coupled receptor (GPCR) family of cell surface receptors that mediate effects inside cells by binding to G proteins or other signalling proteins within the cell membrane and triggering changes in intracellular second messenger formation. It is now clear that there are several different types of adenosine receptors (of which the A3-adenosine receptor is one example) and secondly that these receptors are localised in very tiny and highly specialised regions of the cell membrane called microdomains. These microdomains contain a collection of different molecules that are involved in telling the cell how to respond to drugs or hormones. The aim of this proposal is to use highly sophisticated laser-based microscopy to study the way that drugs bind to A3-receptors in these small membrane microdomains in living cells. This is achieved by using a drug molecule that has a fluorescent label attached to it. The fluorescent drug can then be followed as it binds to the adenosine A3 receptor in real time at the single molecule level. On its own, the small fluorescent drug molecule moves quickly though a laser beam and gives off light (photons). When the drug binds to a single receptor, the complex is much bigger and heavier and so moves much more slowly and gives off a different pattern of light. By analysing the time that each fluorescent molecule is present within the laser beam, we can count the number of free drug molecules and the number of receptor-bound drug molecules that are present. We can also monitor the size of individual receptor-signalling protein complexes from their diffusional characterstics. The ultimate aim of this work is to use these techniques in human cells in disease. To do this we need to develop very specific fluorescent A3-receptor drugs that do not bind to other types of adenosine receptor. When we have designed and made these drugs we will use them to study A3-receptors in specialised human blood cells (neutrophils) that are have important roles during infection and inflammation.</gtr:abstractText><gtr:technicalSummary>G-protein-coupled receptors (GPCRs) are the major target for drug discovery activities. They are single chain membrane proteins that have a heptahelical structure and stimulate intracellular cascades via an interaction with both heterotrimeric G proteins and other signalling proteins (e.g. arrestins). It is now evident, however, that GPCRs are not uniformly distributed at the cell surface, but instead are organized within membrane compartments and microdomains providing a mechanism by which intracellular signalling can be orchestrated in different areas of an individual cell. At the present time, however, there is a dearth of information on the pharmacological properties of GPCRs in these different domains at the single cell level. The aim of this proposal is to use single molecular fluorescent techniques to investigate the pharmacological properties of different conformational states of a GPCR when occupied by agonists, inverse agonists or antagonists in microdomains of single living cells. There are six aspects to this project: (1) To investigate the properties and dffusional characteristics of ligand-bound adenosine A3-receptor complexes in different conformations (both active (R*) and inactive (R)) using the technique of fluorescence correlation spectroscopy (FCS) and fluorescent ligands of differing efficacy; (2) To compare, using FCS, the properties and diffusional characteristics of agonist-occupied active receptors (AR*) alone and in combination with heterotrimeric G proteins (AR*G) in membrane microdomains; (3) to use FCS in conjunction with bimolecular fluorescence complementation (BiFC) techniques in living cells to investigate the diffusional characteristics of specific receptor-effector complexes (i.e. receptor-arrestin, receptor-caveolin, receptor-G protein); (4) To use two colour cross correlation FCS to study in a highly specific manner the pharmacological properties of ligands bound to specific receptor-effector complexes and receptor homodimers; (5) To use simultaneous techniques for monitoring ligand binding and intracellular second messenger responses (calcium ions, ERK phosphorylation and cyclic AMP) to evaluate the agonist efficacy of fluorescent ligands in microdomains of single living cells and (6) To translate these experimental approaches to primary human cells (neutrophils) of immediate relevance to human disease.</gtr:technicalSummary><gtr:fund><gtr:end>2014-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1266699</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Work experience Student - local School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F9CF8907-22F6-4D72-9BD1-1C6423C13516</gtr:id><gtr:impact>We hosted a work experience student for one week in Cell Signalling

The student gained knowledge of scientific research</gtr:impact><gtr:outcomeId>6D2EB23897B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Erasmus placement (Philip Knopff)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0EABD72F-6EAA-4679-BD63-B04E492F361A</gtr:id><gtr:impact>Erasmus placement in Nottingham for one year for an undergraduate from Germany interested in learning FCS</gtr:impact><gtr:outcomeId>56c2d66638c864.49536332</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayfest (Community Open Day)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7D3BCF5B-16E9-42FC-BEE7-EE57EAF784FD</gtr:id><gtr:impact>Community Open Day illustrating the power of microscopy.</gtr:impact><gtr:outcomeId>56c2d5548fdbc8.88179899</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15573</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>Raine Medical Research Foundation</gtr:department><gtr:description>Raine Visiting Professorship 2015-2016</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>University of Western Australia</gtr:fundingOrg><gtr:id>FD0927BA-8B69-4426-B579-01054A0697E8</gtr:id><gtr:outcomeId>56c18fbc2527c6.24735695</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU Marie Curie Fellowship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>B862C398-FAD2-4B83-9A19-C234DE22BE77</gtr:id><gtr:outcomeId>qUZWC983VoZ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8220C11C-BBAE-475C-AD88-775BA0F9826B</gtr:id><gtr:outcomeId>FD9CC25D9440</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16000</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:department>Raine Medical Research Foundation</gtr:department><gtr:description>Raine VIsiting Professor</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>University of Western Australia</gtr:fundingOrg><gtr:fundingRef>NA</gtr:fundingRef><gtr:id>79CEDFC1-9C94-4F0D-8D15-79E823F01727</gtr:id><gtr:outcomeId>QN42TFzY3YB</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>188800</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>AUD</gtr:currCode><gtr:currCountryCode>Australia</gtr:currCountryCode><gtr:currLang>en_AU</gtr:currLang><gtr:description>Australia Research Council Linkage Grant</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Australian Research Council (ARC)</gtr:fundingOrg><gtr:fundingRef>LP130100037</gtr:fundingRef><gtr:id>52700560-3002-467C-8140-3943AEB6467E</gtr:id><gtr:outcomeId>BVoBuZqwy2a</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FC0BEB37-CA6C-4744-B991-9E6A035FBF96</gtr:id><gtr:outcomeId>2153275CE1D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU IMI</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>841F549E-D273-4C97-8053-9EE158A8CBBB</gtr:id><gtr:outcomeId>fVWASbAyjkX</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>374000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welcome Trust Equipment grant</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>82AF6C8E-0C79-4BCC-8D74-CDA644967D00</gtr:id><gtr:outcomeId>gRnn3241yAh0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6638553E-1A9E-48F2-8165-DE5252519F04</gtr:id><gtr:title>Evolution of ?-blockers: from anti-anginal drugs to ligand-directed signalling.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef5c711eb03a444e3f040bba5f06159c"><gtr:id>ef5c711eb03a444e3f040bba5f06159c</gtr:id><gtr:otherNames>Baker JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>r4jdsB3qsYj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F86A4165-CC16-4E2A-91B8-C25D86356B86</gtr:id><gtr:title>Probing the pharmacology of G protein-coupled receptors with fluorescent ligands.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7eb773f07ea294985ca8ca932e6eb"><gtr:id>61a7eb773f07ea294985ca8ca932e6eb</gtr:id><gtr:otherNames>Stoddart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>56b892a5227d63.09963393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6EFD12F-FCED-4EAC-A464-A6626F44CDD4</gtr:id><gtr:title>Biophysical Detection of Diversity and Bias in GPCR Function.</gtr:title><gtr:parentPublicationTitle>Frontiers in endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a77d881eea2d6df68cb58473e0a19f2"><gtr:id>7a77d881eea2d6df68cb58473e0a19f2</gtr:id><gtr:otherNames>Jaeger WC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-2392</gtr:issn><gtr:outcomeId>5453757f76f992.07832266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C7ED94B-2032-432A-8E1F-2980E1CC0416</gtr:id><gtr:title>Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7eb773f07ea294985ca8ca932e6eb"><gtr:id>61a7eb773f07ea294985ca8ca932e6eb</gtr:id><gtr:otherNames>Stoddart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>56b892a56692c5.37492761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF1D10CA-B808-4A2E-B951-E4BCF973CB5C</gtr:id><gtr:title>Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human-adrenoceptor expressed in HEK-293 cells.</gtr:title><gtr:parentPublicationTitle>Pharmacology research &amp; perspectives</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/163a9889a4bebad5bbbd96c48b1c5547"><gtr:id>163a9889a4bebad5bbbd96c48b1c5547</gtr:id><gtr:otherNames>Soave M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2052-1707</gtr:issn><gtr:outcomeId>58a1d937afa4f0.81028209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>866AEE13-ED97-45D0-9002-1B01976591FD</gtr:id><gtr:title>The effect of allosteric modulators on the kinetics of agonist-G protein-coupled receptor interactions in single living cells.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c08b380da3126c36d28d25c3d52d65b"><gtr:id>4c08b380da3126c36d28d25c3d52d65b</gtr:id><gtr:otherNames>May LT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>bef5gfGtEkP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6AC92DE-94E1-4689-99A0-412CE5DC6147</gtr:id><gtr:title>Application of BRET to monitor ligand binding to GPCRs.</gtr:title><gtr:parentPublicationTitle>Nature methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7eb773f07ea294985ca8ca932e6eb"><gtr:id>61a7eb773f07ea294985ca8ca932e6eb</gtr:id><gtr:otherNames>Stoddart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1548-7091</gtr:issn><gtr:outcomeId>5675e58e17213</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60451CE4-6CAD-4776-91C9-1790830747DB</gtr:id><gtr:title>The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/606b7892609cbaa3a8b64b5bc9b3029f"><gtr:id>606b7892609cbaa3a8b64b5bc9b3029f</gtr:id><gtr:otherNames>Vernall AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14173_23_23734587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D91916D-7C4F-42C6-B601-A1B6E87B9CEB</gtr:id><gtr:title>Adenylyl cyclase AC8 directly controls its micro-environment by recruiting the actin cytoskeleton in a cholesterol-rich milieu.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e762bb13317b53634062e5fe47eebdf"><gtr:id>5e762bb13317b53634062e5fe47eebdf</gtr:id><gtr:otherNames>Ayling LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14173_23_22399809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17EAFC79-87AF-4F74-A878-964AA5FD358E</gtr:id><gtr:title>A novel fluorescent histamine H(1) receptor antagonist demonstrates the advantage of using fluorescence correlation spectroscopy to study the binding of lipophilic ligands.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0651af202e8339feda7ced57bb9b7731"><gtr:id>0651af202e8339feda7ced57bb9b7731</gtr:id><gtr:otherNames>Rose RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>GQGNt2iPAnE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19308FEF-62CB-4E48-BD40-31B4FCA89AF0</gtr:id><gtr:title>A Perspective on Studying G-Protein-Coupled Receptor Signaling with Resonance Energy Transfer Biosensors in Living Organisms.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1faabaf4f83e9d65148b098110214a45"><gtr:id>1faabaf4f83e9d65148b098110214a45</gtr:id><gtr:otherNames>van Unen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>56b892a4e25f72.34244867</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EED398C5-111F-45D6-A24E-C9FA499B00D9</gtr:id><gtr:title>Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c08b380da3126c36d28d25c3d52d65b"><gtr:id>4c08b380da3126c36d28d25c3d52d65b</gtr:id><gtr:otherNames>May LT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>FpSHg83pbuA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B79D982C-6669-499B-98A1-1DDFEB101159</gtr:id><gtr:title>Detection of the secondary, low-affinity ?1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f2d26d2145b28b31abb3e0794855665"><gtr:id>1f2d26d2145b28b31abb3e0794855665</gtr:id><gtr:otherNames>Gherbi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>545371065bc9f1.61343618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB090B78-8BAC-4EA4-B937-F71BFB199BE0</gtr:id><gtr:title>Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef5c711eb03a444e3f040bba5f06159c"><gtr:id>ef5c711eb03a444e3f040bba5f06159c</gtr:id><gtr:otherNames>Baker JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>545375c81842b7.80810533</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F847D95-EE03-4C9B-A1D2-46995DA7329A</gtr:id><gtr:title>Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7eb773f07ea294985ca8ca932e6eb"><gtr:id>61a7eb773f07ea294985ca8ca932e6eb</gtr:id><gtr:otherNames>Stoddart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>585d3937e1ee39.47266596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6E5578E-8609-4009-A6FC-1AE50AC78721</gtr:id><gtr:title>Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1fe5c50af954f19b6f93b345173d6d"><gtr:id>8d1fe5c50af954f19b6f93b345173d6d</gtr:id><gtr:otherNames>Hill SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14173_23_24024783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA3187F-EE3C-417D-81E9-97387D8B2567</gtr:id><gtr:title>Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7eb773f07ea294985ca8ca932e6eb"><gtr:id>61a7eb773f07ea294985ca8ca932e6eb</gtr:id><gtr:otherNames>Stoddart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_14173_23_22999879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30B52E53-F84E-4144-A3E0-7E30BA6EB9CA</gtr:id><gtr:title>Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactions.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c08b380da3126c36d28d25c3d52d65b"><gtr:id>4c08b380da3126c36d28d25c3d52d65b</gtr:id><gtr:otherNames>May LT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>TRgKh5VMQQv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60BA5253-E638-476C-9720-E03961D5BF06</gtr:id><gtr:title>Negative cooperativity across ?1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 ?1-adrenoceptor binding conformation.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f2d26d2145b28b31abb3e0794855665"><gtr:id>1f2d26d2145b28b31abb3e0794855665</gtr:id><gtr:otherNames>Gherbi K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5675e1c74b14c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>384F3974-5CA2-4932-B2A6-99637A366420</gtr:id><gtr:title>Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/606b7892609cbaa3a8b64b5bc9b3029f"><gtr:id>606b7892609cbaa3a8b64b5bc9b3029f</gtr:id><gtr:otherNames>Vernall AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>pm_14173_23_23881285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFB07452-DA30-4BD5-89E6-AE9BC4F9ADA9</gtr:id><gtr:title>Adenosine-A3 receptors in neutrophil microdomains promote the formation of bacteria-tethering cytonemes.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58bf07973b05f2442581d59f1523ae3"><gtr:id>b58bf07973b05f2442581d59f1523ae3</gtr:id><gtr:otherNames>Corriden R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>pm_14173_23_23817552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>632D861F-3B39-4CFA-9F91-CD97DCEA72C6</gtr:id><gtr:title>Ligand Residence Time at G-protein-Coupled Receptors-Why We Should Take Our Time To Study It.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9de87529211925e41b46e1ce324ae374"><gtr:id>9de87529211925e41b46e1ce324ae374</gtr:id><gtr:otherNames>Hoffmann C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>5675e80d85506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D97314B-E1CF-4932-9E86-CF37E62BC9D3</gtr:id><gtr:title>Effect of a toggle switch mutation in TM6 of the human adenosine A3 receptor on Gi protein-dependent signalling and Gi-independent receptor internalization.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7eb773f07ea294985ca8ca932e6eb"><gtr:id>61a7eb773f07ea294985ca8ca932e6eb</gtr:id><gtr:otherNames>Stoddart LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>5453717b736762.68867949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC842ECB-7245-4361-8EDD-A3B3E6C3859E</gtr:id><gtr:title>Highly potent and selective fluorescent antagonists of the human adenosine A3 receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/606b7892609cbaa3a8b64b5bc9b3029f"><gtr:id>606b7892609cbaa3a8b64b5bc9b3029f</gtr:id><gtr:otherNames>Vernall AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>pm_14173_23_22277057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EB67EF9-EFFB-43D2-8735-0AFA2615C66D</gtr:id><gtr:title>The use of fluorescence correlation spectroscopy to characterize the molecular mobility of fluorescently labelled G protein-coupled receptors.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e06ce4488798b2fbd32e279b7a1a9adc"><gtr:id>e06ce4488798b2fbd32e279b7a1a9adc</gtr:id><gtr:otherNames>Kilpatrick LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>58a1d9ad3148a4.64778999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A72B8682-DC1D-4A9F-A972-928AC5ADA6DF</gtr:id><gtr:title>A monoclonal antibody raised against a thermo-stabilised ?-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of ?-adrenoceptors expressed in stable cell lines.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/163a9889a4bebad5bbbd96c48b1c5547"><gtr:id>163a9889a4bebad5bbbd96c48b1c5547</gtr:id><gtr:otherNames>Soave M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>5a82caa8bc09a5.78578252</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AD53330-A52D-4E13-A154-4AC1FD447043</gtr:id><gtr:title>Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b58bf07973b05f2442581d59f1523ae3"><gtr:id>b58bf07973b05f2442581d59f1523ae3</gtr:id><gtr:otherNames>Corriden R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>545371485de648.62723388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>315714D0-57C3-4174-AD02-21B8378AF135</gtr:id><gtr:title>Fluorescence Approaches Unravel Spatial and Temporal Aspects of GPCR Organisation, Location, and Intracellular Signalling.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1fe5c50af954f19b6f93b345173d6d"><gtr:id>8d1fe5c50af954f19b6f93b345173d6d</gtr:id><gtr:otherNames>Hill SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>5a82caa79b00a3.60127061</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E60519F7-AF46-4F04-8AE1-6D544A945022</gtr:id><gtr:title>GPCR signaling: understanding the pathway to successful drug discovery.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f79c0af4919e81651d162c148e4b43a4"><gtr:id>f79c0af4919e81651d162c148e4b43a4</gtr:id><gtr:otherNames>Williams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>JeZ8RaNs3w3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D41F6AFB-643E-4C5B-8F5B-D24737FE1F82</gtr:id><gtr:title>Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human ?-adrenoceptors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef5c711eb03a444e3f040bba5f06159c"><gtr:id>ef5c711eb03a444e3f040bba5f06159c</gtr:id><gtr:otherNames>Baker JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>pm_14173_23_21870877</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADF15382-00FF-4B2F-97F9-DC9A08F903CB</gtr:id><gtr:title>Characterisation of endogenous Aand Areceptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor? biosensor: Evidence for an allosteric mechanism of action for the A-selective antagonist PSB 603.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ad12f521963eb3602f7aeea5be777af"><gtr:id>0ad12f521963eb3602f7aeea5be777af</gtr:id><gtr:otherNames>Goulding J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>5a82caa738a336.19921680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>231F5008-ADAE-45F7-BCA8-5ED096559E7E</gtr:id><gtr:title>A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-AReceptor in Living Cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50678a5d48368b15c334984e9aae4dc5"><gtr:id>50678a5d48368b15c334984e9aae4dc5</gtr:id><gtr:otherNames>Arruda MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>5a351881cae940.53807397</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23FC6524-75D5-40C5-9AC2-B113F698EB72</gtr:id><gtr:title>Fragment-Based Discovery of Subtype-Selective Adenosine Receptor Ligands from Homology Models.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74414b4e36bc87169804e82dbd16b40f"><gtr:id>74414b4e36bc87169804e82dbd16b40f</gtr:id><gtr:otherNames>Ranganathan A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>56b892a4a60402.11567552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD05F4CA-44A3-4F82-8600-12857B5F7102</gtr:id><gtr:title>Predicting in vivo cardiovascular properties of ?-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef5c711eb03a444e3f040bba5f06159c"><gtr:id>ef5c711eb03a444e3f040bba5f06159c</gtr:id><gtr:otherNames>Baker JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>HoSM4Xo9i6p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C25E7021-D21C-43B3-8075-C2122FBFB74D</gtr:id><gtr:title>Design and use of fluorescent ligands to study ligand-receptor interactions in single living cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f266344f7f4ba2c640719efcd034514e"><gtr:id>f266344f7f4ba2c640719efcd034514e</gtr:id><gtr:otherNames>Briddon SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>bU4FY4DFQsU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AFB7FD0-F3BD-4ED6-B085-DB4F2ED9DABC</gtr:id><gtr:title>Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0651af202e8339feda7ced57bb9b7731"><gtr:id>0651af202e8339feda7ced57bb9b7731</gtr:id><gtr:otherNames>Rose RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_14173_23_20015298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1263A5D-F42D-4C76-B1D5-7537636712FA</gtr:id><gtr:title>Insights into GPCR pharmacology from the measurement of changes in intracellular cyclic AMP; advantages and pitfalls of differing methodologies.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1fe5c50af954f19b6f93b345173d6d"><gtr:id>8d1fe5c50af954f19b6f93b345173d6d</gtr:id><gtr:otherNames>Hill SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>U2jqQBNUoJp</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800006</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>